CoChat

Randomized controlled trial of an Acceptance and Commitment Therapy and compassion-based group intervention for persons with inflammatory bowel disease: the LIFEwithIBD intervention

Open access

The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index; 11 of the 21 sources its claims cite were checked for support.

Abstract

Objectives: This study tested the acceptability and efficacy of an Acceptance and Commitment Therapy and compassion-based intervention (LIFEwithIBD) in people with IBD through a two-arm RCT. Methods: Participants were recruited at the Gastroenterology Department of the Coimbra University Hospital between June and September 2019. Of the 355 patients screened, those who accepted to participate were randomly assigned to one of two conditions: experimental group (LIFEwithIBD; n = 25) or control group (waitlist; n = 29). Participants completed self-report measures at baseline (T0), post-intervention (T1), and 3-month (T2) and 12-month (T3) follow-ups. Intervention acceptability was assessed. Efficacy was examined using intent-to-treat ANCOVA at post-intervention after adjusting for baseline values of depressive, anxiety, and stress symptoms (primary outcomes). Linear mixed models for all longitudinal outcomes were also analysed. Inflammatory and disease biomarkers were determined at T0 and T3. Results: Acceptability results revealed a high level of satisfaction and perceived usefulness regarding the intervention. Both groups experienced a significant decrease in stress symptoms and IBD symptom perception at T1. No significant differences were observed at follow-up for the primary outcomes. The experimental group reported significantly lower Crohn’s disease Symptom severity at T2 than the control group. Post-hoc analyses designed to mitigate floor effects revealed substantial treatment effects for the experimental group regarding anxiety symptoms. No significant differences were observed in clinical biomarkers from T0 to T3. Conclusion: The LIFEwithIBD intervention shows promising, although preliminary, benefits for managing disease activity and reducing anxiety symptoms in IBD patients with high severity of psychological distress. Clinical trial registration: https://www.clinicaltrials.gov/ct2/show/NCT03840707, identifier NCT03840707. Copyright © 2024 Ferreira, Pereira, Skvarc, Oliveira, Galhardo, Ferreira, Lucena-Santos, Carvalho, Matos-Pina, Rocha, Portela and Trindade.

Overview

CoChat Summary

## TL;DR

This two-arm randomized controlled trial tested the acceptability and preliminary efficacy of the LIFEwithIBD ACT- and compassion-based group intervention in people with inflammatory bowel disease (IBD). The intervention was well accepted, but it did not improve the primary distress outcomes versus control at follow-up, with limited signals for anxiety and Crohn’s disease symptom severity.

## Key findings

  • Of 355 patients screened, 76 were randomized: 38 to LIFEwithIBD + TAU and 38 to TAU; 23 later self-excluded before the intervention began, leaving 25 in the experimental group and 29 in the control group in the abstracted analysis.
  • Acceptability was high: “all participants” said the intervention was worthwhile and would recommend it to another person with IBD; most considered it high quality and useful.
  • No significant between-group differences were found at post-treatment on the primary outcomes (DASS-21 depression, anxiety, stress) after adjusting for baseline scores, and no significant differences were seen at follow-up for the primary outcomes.
  • Secondary findings were limited: the experimental group had significantly lower Crohn’s disease symptom severity at 3 months (T2) than control (ηp² = 0.155, p = 0.042), and exploratory analysis found a significant post-treatment anxiety difference (F(1,13) = 7.56, p = 0.017, ηp² = 0.368). No significant biomarker differences were observed from T0 to T3, except albumin increased in the control group (p = 0.004) and showed a nonsignificant trend in the experimental group (p = 0.066).

## Methods

  • Two-arm RCT recruiting adults with IBD from the Gastroenterology Department of Coimbra University Hospital between June and September 2019; inclusion required age 18–65, Portuguese literacy, IBD diagnosis for at least 6 months, and informed consent.
  • Randomized conditions: LIFEwithIBD + treatment as usual versus waitlist/treatment as usual; participants completed self-report measures at baseline (T0), post-intervention (T1), 3 months (T2), and 12 months (T3), with biomarkers measured at T0 and T3.
  • Main analyses used intent-to-treat ANCOVA for post-intervention outcomes adjusting for baseline values, linear mixed models for longitudinal outcomes, and two-way ANOVA/Sidak tests for biomarkers; acceptability was assessed via post-intervention questionnaire.

## Limitations

  • The paper explicitly states a relatively small sample size and a considerable attrition rate.
  • The authors state that participants in both groups had low baseline psychological distress, which may have reduced sensitivity to change; they suggest future studies include patients with higher distress.
  • The paper explicitly notes reliance on self-report questionnaires and baseline differences in self-critical attitude and psychological flexibility between groups.
  • Evident from the text: some post-hoc analyses were exploratory with no correction for multiple comparisons, and COVID-19 lockdown periods coincided with later assessments, which could have affected results.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.3389/fpsyg.2024.1367913

Cites

36 of 36 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 CONSORT flow diagram. *Participants with three consecutive absences or who attended less than two-thirds of the intervention were considered intervention non-completers.
Figure 1 CONSORT flow diagram. *Participants with three consecutive absences or who attended less than two-thirds of the intervention were considered intervention non-completers.CC BY · PubMed Central

Verification

Claims the paper makes

7 Valid · 1 Not valid · 3 Not checked · 37 Own results and interpretations

16 more claims

Create a free account to see all 48 claims and every source verdict.

See all claims — free account
  • Probably not a substantial claim. 8
  • It may state two separate claims as one. 21

Create a free account to see these claims.

Statistics recomputed

Every reported test result, recomputed from its test statistic and degrees of freedom. A result shows as not adding up only once an independent check has confirmed it.

  • ConsistentF(1, 13) = 3.613reported p = .08 · recomputed p = .080

    “F(1,13) = 3.613, p = .08”

  • ConsistentF(1, 4) = 1.65reported p = .268 · recomputed p = .268

    “F(1,4) = 1.65, p = .268”

  • ConsistentF(1, 13) = 7.56reported p = .017 · recomputed p = .017

    “F(1,13) = 7.56, p = .017”

3 of 3

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

1 of 1

Citations

Cites

Show all 36 references

Research works printed but not linked: 2

  1. Fox, 2012, Package ‘car’
  2. Palha, 2016, Perspetiva sobre a Saúde mental em Portugal: perspective on mental health in Portugal, Gazeta Médica

Cited by

See all 12

Metadata

Authors
Ferreira, C., Pereira, J., Skvarc, D., Oliveira, S., Galhardo, A., Ferreira, N. B., Lucena-Santos, P., Carvalho, S. A., Matos-Pina, I., Rocha, B. S., Portela, F., & Trindade, I. A.
Affiliations
  • University of Coimbra (PT)
  • Örebro University (SE)
  • Instituto Superior Miguel Torga (PT)
  • University of Nicosia (CY)
  • Centro de Neurociências e Biologia Celular (PT)
  • Unidade Local de Saúde de Coimbra (PT)
Corresponding author
  • Ferreira, Cláudia
  • Trindade, Inês A.
Venue
Frontiers in Psychology
Published
2024-05-09
Volume
15
Pages
1367913-1367913
ISSN
1664-1078 (ISSN-L)
OpenAlex
W4396771767
Cited by
12
References
36
Citations by year
2026: 5 · 2025: 6 · 2024: 1
FWCI
5.99
Type
journal article
Language
en
Open access
Locations
  • Frontiers in Psychology (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Figshare (submittedVersion, cc-by)
  • Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) (submittedVersion, other-oa)
Topics
  • Social Sciences › Psychology › Clinical Psychology › Mindfulness and Compassion Interventions
  • Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
  • Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
Keywords
inflammatory bowel disease, acceptance and commitment therapy, compassion-focused therapy, group intervention, psychological distress, anxiety symptoms, stress symptoms, depression, treatment acceptability, inflammatory markers

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Randomized controlled trial of an Acceptance and Commitment Therapy and compassion-based group intervention for persons with inflammatory bowel disease: the LIFEwithIBD intervention. https://app.cochat.ai/papers/10.3389/fpsyg.2024.1367913
The paper
Ferreira, C., Pereira, J., Skvarc, D., Oliveira, S., Galhardo, A., Ferreira, N. B., Lucena-Santos, P., Carvalho, S. A., Matos-Pina, I., Rocha, B. S., Portela, F., & Trindade, I. A. (2024). Randomized controlled trial of an Acceptance and Commitment Therapy and compassion-based group intervention for persons with inflammatory bowel disease: the LIFEwithIBD intervention. Frontiers in Psychology. https://doi.org/10.3389/fpsyg.2024.1367913

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.